Recent data have provided evidence that microglia, the brain-resident macrophage-like cells, modulate neuronal activity in both physiological and pathophysiological conditions, and microglia are therefore now recognized as synaptic partners. Among different neuromodulators, purines, which are produced and released by microglia, have emerged as promising candidates to mediate interactions between microglia and synapses. The cellular effects of purines are mediated through a large family of receptors for adenosine and for ATP (P2 receptors). These receptors are present at brain synapses, but it is unknown whether they can respond to microglia-derived purines to modulate synaptic transmission and plasticity. Here, we used a simple model of adding immune-challenged microglia to mouse hippocampal slices to investigate their impact on synaptic transmission and plasticity at hippocampal mossy fibre (MF) synapses onto CA3 pyramidal neurons. MF-CA3 synapses show prominent forms of presynaptic plasticity that are involved in the encoding and retrieval of memory. We demonstrate that microglia-derived ATP differentially modulates synaptic transmission and short-term plasticity at MF-CA3 synapses by acting, respectively, on presynaptic P2X 4 receptors and on adenosine A 1 receptors after conversion of extracellular ATP to adenosine. We also report that P2X 4 receptors are densely located in the mossy fibre tract in the dentate gyrus-CA3 circuitry. In conclusion, this study reveals an interplay between microglia-derived purines and MF-CA3 synapses, and highlights microglia as potent modulators of presynaptic plasticity.
Introduction
Microglia are brain-resident macrophage-like cells of the central nervous system, and have been recently acknowledged as synaptic partners (Ben Achour & Pascual, 2010; Tremblay et al., 2010; Kettenmann et al., 2013) . Microglia modulate neuronal activity in both physiological and pathophysiological conditions (Bessis et al., 2007; Roumier et al., 2008; Wake et al., 2009 ) through signalling mechanisms that are largely unknown. Purines are candidate signals, as microglia can release ATP (Pascual et al., 2012; George et al., 2015) , which modulates synaptic transmission and plasticity (Neary & Zimmermann, 2009; Verkhratsky et al., 2009; Burnstock et al., 2011; Rodrigues et al., 2015) .
ATP has pleiotropic effects in the brain, which depend on different types of purinergic receptors expressed by neurons and glial cells, but also on its degradation by extracellular ectonucleotidases to adenosine (Burnstock et al., 2011; Rodrigues et al., 2015) . Purinergic receptors are divided into two families activated either by adenosine (P1 receptors) or by ATP (P2 receptors). P1 receptors are G-protein-coupled, and comprise four different subtypes: A 1 , A 2A , A 2B , and A 3 . The P2 receptor family is subdivided in two subfamilies: the ionotropic P2X receptors (P2X receptors 1-7) family linked to increased cation permeability, and the metabotropic P2Y receptors (eight different subtypes) family coupled to G-proteins (Burnstock et al., 2011) .
P1 and P2 receptors are widely distributed at brain synapses. In the hippocampus, A 1 receptors (A 1 Rs) are located at both presynaptic and postsynaptic loci (Rebola et al., 2003) , whereas A 2A receptors (A 2A Rs) are mostly presynaptic (Rebola et al., 2005) , but are also present in astrocytes (Matos et al., 2012) and microglia (Rebola et al., 2011) . Adenosine decreases glutamatergic transmission via presynaptic A 1 Rs (Dunwiddie & Masino, 2001) , whereas it activates A 2A Rs to facilitate AMPA and N-methyl-D-aspartate receptormediated currents (Rebola et al., 2008; Dias et al., 2012) to modulate synaptic plasticity (Rebola et al., 2008; Costenla et al., 2011) .
P2X receptors also modulate hippocampal synaptic transmission and plasticity (Pankratov et al., 2002) . Presynaptic P2X 2 receptors facilitate CA3 excitatory transmission onto interneurons in the CA1 region (Khakh et al., 2003) , whereas P2X 4 receptors (P2X 4 Rs) tune the N-methyl-D-aspartate receptor-dependent component of long-term plasticity at the Schaffer-collateral CA1 synapse (Sim et al., 2006) . This is in accordance with the expression of P2X 2 , P2X 3 , P2X 4 and P2X 6 receptor subunits by hippocampal neurons (Rodrigues et al., 2005) , whereas P2X 7 receptors are mostly expressed by activated glial cells (Butt, 2011) .
In this study, we investigated the role of microglia-purine interactions at hippocampal synapses between mossy fibres (MFs) and CA3 pyramidal cells. MF-CA3 synapses show prominent forms of presynaptic plasticity (Marchal & Mulle, 2004; Nicoll & Schmitz, 2005) , and are instrumental in the encoding and retrieval of memories (Nakazawa et al., 2003; Bischofberger et al., 2006; Kesner, 2007) . We report that ATP and adenosine, derived from lipopolysaccharide (LPS)-challenged microglia (George et al., 2015) , do modulate synaptic transmission and short-term plasticity at MF-CA3 synapses by acting, respectively, on P2X 4 Rs and A 1 Rs. This study reveals an interplay between microglia and MF-CA3 synapses, and further supports microglia as true modulators of neuronal network through purinergic modulation of presynaptic function.
Materials and methods

Ethical approval
Experiments were carried out in accordance with the guidelines on the ethical use of animals from the European Communities Council Directive (86/609/EEC) and were evaluated by the Ethics commitee n°50 of Bordeaux, affiliated with the CNREEA (Centre National de Réflexion Ethique sur l'Exp erimentation Animale).
Microglial cell culture and pharmacological treatment
A murine microglial cell line, N9 (a gift from C. Verderio, CNR Institute of Neuroscience, Cellular and Molecular Pharmacology, Milan, Italy), was grown in RPMI-1640 (Sigma, St Quentin Fallavier, France) medium supplemented with 30 mM glucose (Sigma), 5% heat-inactivated fetal bovine serum (Gibco, Invitrogen, Merelbeke, Belgium), 100 lg/mL streptomycin, and 1 U/mL penicillin (Gibco, Invitrogen). Cells were kept at 37°C under a humidified atmosphere with 95% O 2 and 5% CO 2 . In order to trigger microglia activation and ATP release, N9 cells were challenged with 100 ng/ mL LPS (from Escherichia coli, serotype 055:B5; Sigma) for 1 h, which we have found to trigger ATP release and upregulation of A 2A Rs (Gomes et al., 2013) .
Slice preparation
C57BL6/J mice (Janvier Labs, Le Genest St Isle, France) were killed at postnatal day (P)19-P21 by cervical dislocation. The brain was then quickly removed from the skull, and chilled in ice-cold low-calcium artificial cerebrospinal fluid containing 87 mM NaCl, 2.5 mM KCl, 1.25 mM NaH 2 PO 4 , 0.5 mM CaCl 2 , 7 mM MgCl 2 , 10 mM glucose, 25 mM NaHCO 3 , and 75 mM sucrose, adjusted to pH 7.4 by saturating with carbogen (95% O 2 and 5% CO 2 ), and with an osmolarity of 300-310 mOsm. Brains were then glued onto the stage of a vibratome (VT 1200S; Leica, Nusslich, Germany), and parasagittal hippocampal slices (320 lm) were cut. Slices were then transferred to an extracellular solution containing 129 mM NaCl, 2.5 mM KCl, 1.25 mM NaH 2 PO 4 , 2 mM CaCl 2 , 1 mM MgCl 2 , 11 mM glucose, and 25 mM NaHCO 3 , equilibrated with carbogen for 30 min at 33°C and thereafter at room temperature, until being used.
Electrophysiology
The slices were submerged in a recording chamber and continuously superfused with carbogen-saturated extracellular solution at 32-34°C. Whole cell patch clamp recordings were made at a holding potential of À70 mV with electrodes of 3-4 MΩ. Patch clamp electrodes were pulled out from borosilicate glass (GF 150 F-10; Clark Electromedical, Reading, UK), and filled with an internal solution containing 140 mM CsCH 3 SO 3 , 2 mM MgCl 2 , 4 mM NaCl, 5 mM phosphocreatine, 2 mM Na 2 ATP, 0.2 mM EGTA, 10 mM HEPES, and 0.33 mM GTP (pH 7.3), adjusted with CsOH. Bicuculline (10 lM) was added to the bath to inhibit GABA A receptors.
Voltage-clamp recordings were performed on CA3 pyramidal neurons visualized with a differential interference contrast microscope (Eclipse FN-1; Nikon, Champigny sur Marne, France) equipped with an infrared camera (VX44; Till Photonics, Gr€ afelfing, Germany), by use of an Axoptach-200B amplifier (Axon Instruments, Sunnydale, CA, USA). Signals were filtered at 2 kHz and digitized at 5 kHz via a DigiData 1322A interface (Axon Instruments). Series resistance (10-20 MΩ) was monitored during the recording with a À10 mV hyperpolarizing voltage step (length, 50 ms) delivered at the beginning of each recording. Neurons were rejected if the series resistance changed by >20% during the experiment. Neurons with a holding current of >300 pA at a holding potential of À70 mV were rejected. Data were collected and analysed with PCLAMP software 9.2 (Axon Instruments). N9 microglia were challenged with LPS (100 ng/mL) for 1 h or not challenged, before being added to the slices. The cells were trypsinized and collected, and then added to a hippocampal slice at a density of~100 000 cells per slice. N9 cells were allowed to adhere to the slices for 15-20 min, and the unattached cells were washed away, leaving approximately 400-500 cells stuck at the slice surface. Voltage-clamp recordings were obtained from CA3 pyramidal cells surrounded (10-100 lm) by three to five N9 cells in close vicinity. Excitatory postsynaptic currents (EPSCs) from MF-CA3 synapses were evoked by minimal-intensity stimulation of MFs (Marchal & Mulle, 2004; Sachidhanandam et al., 2009) . A glass electrode, with a tip diameter of~1 lm, was placed on the hilus of the dentate gyrus to stimulate MFs. The baseline stimulation frequency for all experiments was 0.1 Hz. EPSCs were identified according to the following criteria: robust low-frequency facilitation, low release probability at low stimulation (0.1 Hz), rapid rise time of individual EPSCs, and being free of secondary peaks during decay. LCCG-1 (10 lM), a metabotropic glutamate receptor 2 agonist, was added routinely to confirm the selective stimulation of MFs, and cells were excluded if the inhibition was <80%. Pyridoxalphosphate-6-azophenyl-2 0 ,4 0 -disulfonic acid (PPADS), ivermectin, 5-(3-bromophenyl)-1,3-dihydro-2H-benzofuro[3,2-e]-1,4-diazepin-2-one (5-BDBD), apyrase, ARL67156 and SCH58261 were obtained from Tocris (Bristol, UK), and 8-cyclopentyl-1,3-dipropylxanthine (DPCPX) and 2-chloro-N 6 -cyclopentyladenosine (CCPA) were obtained from Abcam (Cambridge, UK). The antibody used for staining P2X 4 Rs (Ref. HPA039494) was obtained from Atlas Antibodies (Stockholm, Sweden).
Immunohistochemistry
Mice (P19-P21) were anaesthetized by intraperitoneal administration of pentobarbital (50 mg/kg body weight), and were fixed by transcardial perfusion with 50 mL of 4% paraformaldehyde. Brains were removed and postfixed in 4% paraformaldehyde overnight, and then saturated in a solution with 30% sucrose for 24 h. They were then frozen in cold heptane, and stored at À80°C. Brains were cut on a cryostat at À20°C into 40-lm-thick coronal sections. Sections were collected into antifreeze medium, and stored at À20°C. After a thorough wash in 0.1 M phosphate-buffered saline (PBS) with 0.3% Triton X-100 (PBST), free-floating sections were incubated with 3% normal donkey serum (NDS) with 0.3% Triton X-100 for 20 min at room temperature. Sections were then incubated overnight at 4°C with the primary antibody anti-P2X 4 R (1 : 400) in PBST-NDS solution. Slices were washed three times with 1 9 PBS to rinse off the excess primary antibody before incubation for 2 h at room temperature with Alexa 488 goat anti-rabbit (Synaptic Systems, G€ ottingen, Germany) at 1 : 400 in PBST-NDS solution. After being washed three times with 1 9 PBS, slices were fixed with fluoromont medium containing 4 0 ,6-diamidino-2-phenylindole. Fluorescent images were acquired with a Leica DM6000 TCS SP8X microscope, with a diode laser (excitation -blue, 405 nm; white, 488 nm; and emission -green, 500-560 nm). Images were obtained by mosaic acquisition of the whole hippocampus at 920.
Statistical analysis
Values are presented as mean AE standard error of the mean (SEM), and n indicates the number of different cells. For statistical analysis, non-parametric tests were used. Student's t-test was used for comparison between two groups, and one-way ANOVA followed by a Newman-Keuls post hoc test for comparison between more than two groups. Statistical differences were considered to be significant at P < 0.05. Note that, although the impacts of several drugs and modulators are presented as percentage values for the sake of clarity, statistical comparisons were always carried out with the absolute values. Statistical analysis was performed with PRISM 5.0 (GraphPad Software, La Jolla, CA, USA).
Results
LPS-treated microglia (LPS-microglia) increase basal synaptic transmission at MF-CA3 synapses
We first studied the effect of activated microglia on basal synaptic transmission. For this purpose, N9 microglia were first activated by pretreatment with LPS (100 ng/mL for 1 h) (Gomes et al., 2013) . Activated microglia were then added to acute hippocampal slices with previously described methodology (Centonze et al., 2009 ). In our experimental condition, microglia fully covered the whole hippocampus and surrounded almost every CA3 pyramidal cell ( Fig. 1A and B) . Although microglia do not penetrate deeply into the slice, we recorded CA3 pyramidal cells surrounded (10-100 lm) by an average of three to five microglia in close vicinity, i.e. similar to the estimated density of microglia in the CA3 area (Jinno et al., 2007) . Consistent with previous observations (Centonze et al., 2009) , no noticeable differences in morphology between non-treated microglia (Fig. 1A) and LPS-microglia (Fig. 1B) were observed. However, we have not carried out detailed morphological analysis to determine whether the physical interaction between LPS-microglia and MF-CA3 synapses is similar to the interaction between endogenous microglia and MF-CA3 synapses.
To study basal synaptic transmission, MF-CA3 EPSCs (MFEPSCs) were evoked with a minimal stimulation protocol (Marchal & Mulle, 2004) . The average amplitude of MF-EPSCs recorded at a low stimulation rate (0.1 Hz) (À73 AE 5 pA; n = 10) was consistent with previous observations (Marchal & Mulle, 2004) . The addition of non-treated microglia had no effect on basal synaptic transmission (À76 AE 12 pA; P = 0.8, n = 9) whereas the addition of LPS-microglia increased basal synaptic transmission (À106 AE 12 pA; P < 0.05, n = 9; data not shown) (Table 1) .
LPS-microglia decrease short-term plasticity at MF-CA3 synapses
MF-CA3 synapses are distinct from most other synapses in the central nervous system, because they show prominent forms of presynaptic short-term plasticity (Nicoll & Schmitz, 2005) , including pronounced paired-pulse facilitation (PPF) (two stimulations separated by 10-200 ms), represented by variation of the paired-pulse ratio (PPR) (pulse 2/pulse 1), and frequency facilitation (FF) (tonic stimulation switching from 0.1 Hz to >1 Hz). Activity-dependent neurotransmitter release among central nervous system synapses depends largely on the basal release probability, which is linked to the presynaptic calcium concentration. Hence, PPF at MF-CA3 synapses has been reported to depend solely on the residual calcium concentration in the presynaptic terminal (Salin et al., 1996; Nicoll & Schmitz, 2005) . MF-EPSCs recorded from slices with added LPS-microglia showed decreased PPF, estimated from the PPR, as compared with slices with no added microglia (LPS-microglia, 277 AE 31%; control, 392 AE 32%; P < 0.05, n = 9; Fig. 1C and E) and slices with non-treated microglia added (microglia, 357 AE 35%, n = 9; Fig. 1C and E). Added LPS-microglia also significantly decreased FF as compared with control (LPS-microglia, 281 AE 18%; control, 482 AE 39%; P < 0.001, n = 9; Fig. 1D and F) and slices with non-treated microglia added (microglia, 430 AE 18%; P < 0.05, n = 9; Fig. 1D and F). As both PPF and FF were similar between control slices and slices with added non-treated microglia, our results indicated that the decrease in short-term plasticity observed with added LPS-microglia was probably attributable to the immune challenging of microglia.
Inhibition of microglial A 2A Rs prevents changes in short-term plasticity
The immune challenging of microglia with LPS (100 ng/mL) is known to drive microglia to release ATP, and this is abolished by blocking adenosine A 2A Rs on microglia (Gomes et al., 2013; George et al., 2015) . We thus hypothesized that ATP released from LPS-microglia was involved in the observed changes in short-term synaptic plasticity. Taking advantage of the fact that neuronal presynaptic A 2A Rs do not, as such, modulate basal synaptic transmission or either PPF or FF at MF synapses (Rebola et al., 2008) , we antagonized A 2A Rs on microglia by pre-incubation with the A 2A R antagonist SCH58261 (50 nM) for 20 min (Lopes et al., 2004) prior to activation of microglia by LPS and addition to acute slices.
The pre-incubation of LPS-microglia with SCH58261 significantly reduced the decrease in FF induced by the addition of LPSmicroglia (LPS-microglia, 281 AE 18%; LPS-microglia + SCH58261, 373 AE 27%; P < 0.05, n = 9) ( Fig. 1F ) but had no significant effect on the decrease in PPF (LPS-microglia, 277 AE 31%; LPS-microglia + SCH58261, 324 AE 31%; P = 0.65, n = 9) ( Fig. 1E ; Table 2 ). Thus, the blockade of A 2A Rs in LPSmicroglia alleviated some of the changes observed in MF-CA3 short-term synaptic plasticity. As we have previously shown that A 2A Rs control ATP release from microglia (George et al., 2015) , this supports the hypothesis that ATP released from LPS-microglia might impact on MF-CA3 synaptic activity, leading to changes in short-term synaptic plasticity.
LPS-microglia regulate FF
To further validate the putative role of ATP, released by LPS-microglia, in the observed changes in FF and PPF, we manipulated extracellular ATP by either promoting its degradation with apyrase or by blocking its extracellular degradation with ARL67156 (Frenguelli et al., 2007) . Addition of apyrase (10 U/mL) decreased basal synaptic transmission at low frequency (0.1 Hz) within 5 min (control, 98 AE 1%; apyrase, 54 AE 1%; P < 0.001, n = 4) ( Fig. 2A and B) . In addition, apyrase abolished the decrease in FF induced by LPSmicroglia (LPS-microglia, 281 AE 18%; LPS-microglia + apyrase, 393 AE 24%; P < 0.01, n = 4) (Fig. 2E) . Apyrase also abolished the decrease in PPF induced by LPS-microglia (LPS-microglia, 277 AE 31%; LPS-microglia + apyrase, 466 AE 86%; P < 0.05, n = 4) (Fig. 2F) . Conversely, ARL67156 was used in control slices 
For each experimental condition, values are normalized to control. ↑, increase; ↓, decrease; -, no effect. Graphical representation of the PPR in different conditions. SCH58261 (50 nM) was added for 20 min prior to activation of microglia by LPS (control, 392 AE 32%; microglia, 357 AE 35%; LPSmicroglia, 277 AE 31%; microglia + SCH58261, 336 AE 28%; LPS-microglia + SCH58261, 324 AE 31%; n = 9 for all conditions). (F) Graphical representation of FF in different conditions (control, 482 AE 39%; microglia, 430 AE 18%; LPS-microglia, 281 AE 18%; microglia + SCH58261, 375 AE 39%; LPSmicroglia + SCH58261, 373 AE 27%; n = 9 for all conditions). FF and PPR protocols were performed one after another, on the same cell. Data are represented as mean AE SEM. *P < 0.05, **P < 0.01 and ***P < 0.001 from one-way ANOVA followed by a Newmann-Keuls multiple comparison test.
(no microglia added) to determine whether increasing the endogenous levels of ATP in control conditions could mimic the alterations induced by LPS-microglia. ARL67156 (100 lM) alone did not significantly affect the amplitude of MF-EPSCs recorded at 0.1 Hz (control, 98 AE 1%; ARL67156, 115 AE 13%; P = 0.2, n = 4) ( Fig. 2C and D) , but reduced FF as LPS-microglia did (control, 482 AE 39%; ARL67156, 183 AE 27%, P < 0.001; LPS-microglia, 281 AE 18%, P < 0.001, n = 4) (Fig. 2G ). In contrast, ARL67156 did not significantly affect PPF (control, 392 AE 32%; ARL67156, 374 AE 71%; P = 0.3, n = 3) (Fig. 2H) . Hence, the decrease in FF induced by LPS-microglia was abolished by removal of extracellular ATP, whereas this decrease was mimicked by increased endogenous levels of ATP in control slices. In contrast, modulation of extracellular ATP did not have a significant effect on PPF; that is, manipulating the extracellular levels of ATP did not mimic or abolish the effects of LPS-microglia.
Adenosine is involved in LPS-microglia-mediated regulation of PPF
Our data strongly suggest that ATP is the key molecule responsible for the microglia-induced changes in presynaptic forms of short-term plasticity. However, ATP is readily converted into adenosine by extracellular ectonucleotidases (Cunha et al., 1998) , namely in synapses (Cunha, 2001) , and presynaptic adenosine A 1 Rs are present at MF-CA3 synapses (Scanziani et al., 1992; Moore et al., 2003; Kukley et al., 2005; Rebola et al., 2008) . Therefore, we investigated whether adenosine derived from the ATP released by LPS-microglia could modulate MF-CA3 transmission.
We first studied the effects of CCPA (A 1 R agonist) and of DPCPX [A 1 R antagonist; see Sebastião et al. (2000) ] on FF. As shown in Fig. 3B , DPCPX (100 nM) alone did not significantly change FF (control, 482 AE 39%; DPCPX, 426 AE 87%; P = 0.5, n = 9), in agreement with previous studies (Kukley et al., 2005; Rebola et al., 2008) [but see Moore et al. (2003) ], and also had no effect on basal synaptic transmission (control, 147 AE 18%; DPCPX, 97 AE 3%; P = 0.06, n = 9; data not shown). DPCPX did not abolish the LPS-microglia-induced decrease in FF (LPS-microglia, 281 AE 18%; LPS-microglia + DPCPX, 250 AE 38%; P = 0.8, n = 9) (Fig. 3B ). Furthermore, CCPA (100 nM) did not mimic the effect of LPS-microglia on FF (CCPA, 399 AE 52%; LPS-microglia, 281 AE 18%; P = 0.08, n = 9) (Fig. 3D) . Finally, CCPA did not alter the LPS-microglia-induced decrease in FF (LPS-microglia, 281 AE 18%; LPS-microglia + CCPA, 230 AE 42%; P = 0.2, n = 9) (Fig. 3D) . In contrast, DPCPX prevented the change in PPF induced by LPS-microglia (LPS-microglia, 277 AE 31%; LPSmicroglia + DPCPX, 383 AE 35%, P > 0.05, n = 9) (Fig. 3C) . Conversely, CCPA decreased PPF when added to control slices (control, 392 AE 32%; CCPA, 269 AE 38%; P > 0.05, n = 9) (Fig. 3E) , mimicking the effect of LPS-microglia.
Taken together, these results indicate that the level of extracellular adenosine in our experimental conditions was moderate, as estimated by the lack of a significant effect of DPCPX on basal synaptic transmission, and show that, whereas adenosine produced by the breakdown of released ATP from LPS-microglia has no effect on FF, it modulates PPF.
P2X 4 Rs modulate short-term synaptic plasticity
To further characterize the role of ATP derived from LPS-microglia in the modulation of FF, we investigated which subtype of purinergic receptor was involved. ATP can bind to metabotropic (P2Y) and ionotropic (P2X) receptors. A role of P2X receptors has been reported in hippocampal synapses, mostly in the context of synaptic plasticity (Soto et al., 1996; Khakh et al., 1999; Pankratov et al., 2002; Priel & Silberberg, 2004; Sim et al., 2006; Pougnet et al., 2014) . As shown in Fig. 4A , the effect of LPS-microglia on FF was prevented by blocking P2X receptors with the broad-spectrum antagonist PPADS (50 lM) (Lambrecht et al., 2002 ) (LPS-microglia, 281 AE 18%; LPS-microglia + PPADS, 427 AE 56%; P > 0.05, n = 9). In contrast, PPADS had no effect on the decrease in PPF induced by LPS-microglia (LPS-microglia, 277 AE 31%; LPSmicroglia + PPADS, 281 AE 22%; P = 0.9, n = 9) (Fig. 4B) . These results provide evidence that P2X receptors specifically modulated FF, and not PPF.
We next investigated which subtype of P2X receptor was responsible for the effect of LPS-microglia on FF. The presynaptic expression of P2X 7 Rs at MFs remains controversial (Armstrong et al., 2002; Sperl agh et al., 2002; Kukley et al., 2004; Yu et al., 2008) , whereas the involvement of P2X 4 Rs in the modulation of synaptic strength (Baxter et al., 2011) and/or plasticity has been documented (Sim et al., 2006) at CA3-CA1 synapses. However, the presence of P2X 4 Rs at MF synapses remains to be studied. We first investigated whether P2X 4 Rs were involved in the modulation of basal synaptic transmission. Application of the selective P2X 4 R antagonist 5-BDBD (10 lM) (Donnelly-Roberts et al., 2008) decreased basal synaptic transmission at low frequency (0.1 Hz) within 5 min of its addition (control, 98 AE 1%; 5-BDBD, 65 AE 4%; P < 0.001, n = 9) ( Fig. 4C and D) . Conversely, ivermectin (3 lM), a positive allosteric modulator of P2X 4 Rs that potentiates P2X 4 R currents (Khakh et al., 1999; Sim et al., 2006) , increased basal synaptic transmission at low frequency (0.1 Hz) within 10 min of its addition (control, 98 AE 1%; ivermectin, 128 AE 7%; P < 0.05, n = 6) ( Fig. 4E and F) . Consistent with these results, basal synaptic transmission was also decreased in slices obtained from P2X 4 R knockout (KO) mice (control, 98 AE 1%; P2X 4 R KO, 85 AE 6%; P < 0.05, n = 9; data not shown). Therefore, ATP modulates basal synaptic transmission at MF-CA3 synapses through P2X 4 Rs.
We then investigated the putative role of P2X 4 Rs in the modulation of FF. Selective blockade of P2X 4 Rs with 5-BDBD on its own had no effect on FF (control, 482 AE 39%; 5-BDBD, 438 AE 25%; P = 0.12, n = 9), whereas potentiation of P2X 4 Rs by ivermectin significantly decreased FF (control, 482 AE 39%; ivermectin, 344 AE 35%; P < 0.05, n = 9) (Fig. 4G) . Conversely, 5-BDBD on its own decreased PPF (control, 392 AE 32%; 5-BDBD, 227 AE 16%; P < 0.01, n = 9), whereas ivermectin had no effect (control, 392 AE 32%; ivermectin, 369 AE 40%; P = 0.66, n = 9) (Fig. 4H) .
These results provide good evidence that activation of P2X 4 Rs modulates FF but not PPF, and suggest a presynaptic site of action for ATP. To further strengthen the hypothesis of presynaptic localization of P2X 4 Rs, we used a new antibody raised against P2X 4 Rs and checked its specificity in slices from P2X 4 R KO mice. As 
For each experimental condition, values are normalixed to LPS-microglia. ↑, increase; ↓, decrease; -, no effect.
shown in Fig. 4I Apyrase abolished the effect of LPS-microglia on FF (control, 482 AE 39%, n = 9; apyrase, 444 AE 69%, n = 4; LPS-microglia, 281 AE 18%, n = 9; LPSmicroglia + apyrase, 393 AE 24%, n = 4). (F) Graphical representation of PPR. Apyrase abolished the reduction in PPR induced by LPS-microglia (control, 392 AE 32%, n = 9; apyrase, 301 AE 34%, n = 4; LPS-microglia, 277 AE 31%, n = 9; LPS-microglia + apyrase, 466 AE 86%, n = 4). (G) Graphical representation of FF. Addition of ARL67156 (100 lM) mimicked the LPS-microglia-induced decrease in FF (control, 482 AE 39%, n = 9; LPS-microglia, 281 AE 18%, n = 9; ARL67156, 183 AE 27%, n = 3). (H) Graphical representation of PPR. Increasing the extracellular level of ATP with ARL67156 (100 lM) had no effect on PPR (control, 392 AE 32%, n = 9; LPS-microglia, 277 AE 31%, n = 9; ARL67156, 374 AE 71%, n = 3). Values in all graphs are mean AE SEM. *P < 0.05, **P < 0.01 and ***P < 0.001 from one-way ANOVA followed by a Newmann-Keuls multiple comparison test.
recognize different known molecular structures of homomeric P2X 4 Rs (Zemkova et al., 2015) , different known heteromeric receptor complexes containing P2X 4 R subunits (Antonio et al., 2014) , or P2X 4 Rs with different subcellular localizations (Xu et al., 2014) .
P2X 4 Rs mediate the LPS-microglia-induced decrease in FF
We then investigated the possible involvement of P2X 4 Rs in the modulation of FF by LPS-microglia. Blockade of P2X 4 Rs in hippocampal slices before the addition of LPS-microglia prevented the decrease in FF (LPS-microglia + 5-BDBD, 378 AE 28%; LPS-microglia, 281 AE 18%; P < 0.01, n = 9) (Fig. 5B ) but did not alleviate the decrease in PPF (LPS-microglia + 5-BDBD, 242 AE 25%; LPSmicroglia, 277 AE 31%; P = 0.09, n = 9) (Fig. 5C ). Because P2X 4 Rs are also dynamically involved in controlling endogenous microglia (Toulme & Khakh, 2012; Koizumi et al., 2013) as well as N9 microglia (Xiang & Burnstock, 2005) , we investigated whether the effect of 5-BDBD was attributable to P2X 4 Rs expressed at MF-CA3 synapses or those expressed by N9 microglia added to the slice. For this purpose, LPS-microglia were added to hippocampal slices obtained from P2X 4 R KO mice. The decrease in FF induced by LPS-microglia was reduced in slices obtained from P2X 4 R KO mice (LPS-microglia + P2X 4 R KO, 337 AE 23%; LPS-microglia, 281 AE 18%; P < 0.05, n = 6) ( Fig. 5D) , whereas the decrease in PPF induced by LPS-microglia was preserved in slices from P2X 4 R KO mice (LPS-microglia + P2X 4 R KO, 265 AE 41%; LPS-microglia, 277 AE 31%; P = 0.8, n = 9) (Fig. 5E) .
The ectonucleotidase inhibitor ARL67156 (10 lM) mimicked the LPS-microglia-induced decrease in FF (control, 482 AE 39%, n = 9; Rs by DPCPX (100 nM) had no effect on the LPS-microglia-induced change in FF (control, 482 AE 39%; DPCPX, 426 AE 87%; microglia, 430 AE 18%; microglia + DPCPX, 367 AE 41%; LPS-microglia, 281 AE 18%; LPS-microglia + DPCPX, 250 AE 38%; n = 9 for all conditions). (C) Graphical representation of the PPR. Blockade of A 1 Rs inhibited the reduction in the PPR induced by LPS-microglia (control, 392 AE 32%; DPCPX, 326 AE 18%; microglia, 357 AE 35%; microglia + DPCPX, 333 AE 29%; LPS-microglia, 277 AE 31%; LPS-microglia + DPCPX, 383 AE 35%; n = 9 for all conditions). (D) Graphical representation of FF. CCPA (100 nM) did not alter the LPS-microglia-induced decrease in FF (control, 482 AE 39%; CCPA, 399 AE 52%; microglia, 430 AE 18%; microglia + CCPA, 382 AE 48%; LPS-microglia, 281 AE 18%; LPS-microglia + CCPA, 230 AE 42%; n = 9 for all conditions). (E) Graphical representation of the PPR. CCPA decreased the PPR, mimicking the effect of LPS-microglia (control, 392 AE 32%; CCPA, 269 AE 38%; microglia, 357 AE 35%; microglia + CCPA, 270 AE 25%; LPS-microglia, 277 AE 31%; LPS-microglia + CCPA, 259 AE 37%; n = 9 for all conditions). Values in all graphs are mean AE SEM. *P < 0.05, **P < 0.01 and ***P < 0.001 from one-way ANOVA followed by a Newmann-Keuls multiple comparison test. Fig. 4 . Extracellular ATP modulates basal synaptic transmission and FF via presynaptic P2X 4 Rs. (A) Graphical representation of FF. PPADS (50 lM) blocked the LPS-microglia-induced decrease in FF (control, 482 AE 39%; LPS-microglia, 281 AE 18%; LPS-microglia + PPADS, 427 AE 56%; n = 9 for all conditions). (B) Graphical representation of PPR. PPADS (50 lM) had no effect on the LPS-microglia-induced decrease in PPR (control, 392 AE 32%; LPS-microglia, 277 AE 31%; LPS-microglia + PPADS, 281 AE 22%; P = 0.9, n = 9 for all conditions). (C) Summary plot of the effect of 5-BDBD (10 lM) on basal synaptic transmission. 5-BDBD induced a decrease in basal synaptic transmission within 5 min of addition (control, black squares; 5-BDBD, open squares). (D) Graphical representation of the basal synaptic transmission shown in C (control, 98 AE 1%; 5-BDBD, 65 AE 4%; n = 9 for both conditions). (E) Summary plot of the effect of ivermectin (3 lM) on basal synaptic transmission. Ivermectin increased basal synaptic transmission within 10 min of addition (control, black squares; ivermectin, open squares). (F) Graphical representation of the basal synaptic transmission shown in E (control, 98 AE 1%, n = 9; ivermectin, 128 AE 7%, n = 6). The values in A, B, D and F are mean AE SEM; *P < 0.05 and ***P < 0.001, unpaired t-test. (G) Graphical representation of FF. Ivermectin (3 lM) decreased FF, whereas 5-BDBD (10 lM) had no effect (control, 482 AE 39%, n = 9; ivermectin, 344 AE 35%, n = 6; 5-BDBD, 438 AE 25%, n = 9). (H) Graphical representation of PPR. 5-BDBD (10 lM) decreased PPR, whereas ivermectin (3 lM) had no effect (control, 392 AE 32%, n = 9; ivermectin, 369 AE 40%, n = 6; 5-BDBD, 227 AE 16%, n = 9). The values in G and H are mean AE SEM; *P < 0.05 and **P < 0.01 from one-way ANOVA followed by a Newmann-Keuls multiple comparison test. (I) The hippocampal MFs showed strong immunostaining for P2X 4 R (green) in a wild-type (WT) mouse (upper panel), whereas it was virtually absent in a slice from a P2X 4 R KO mouse (lower panel). 4
0 ,6-Diamidino-2-phenylindole staining for nuclei is shown in blue. Scale bar: 200 lm. Rs by 5-BDBD (10 lM) inhibited the effect of LPS-microglia on FF (control, 482 AE 39%; 5-BDBD, 438 AE 25%; microglia, 430 AE 18%; microglia + 5-BDBD, 374 AE 35%; LPS-microglia, 281 AE 18%; LPS-microglia + 5-BDBD, 378 AE 28%; n = 9 for all conditions). (C) Graphical representation of the PPR. 5-BDBD (10 lM) had no effect on the decrease in the PPR induced by LPS-microglia, whereas it reduced it when applied alone (control, 392 AE 32%; 5-BDBD, 227 AE 16%; microglia, 357 AE 35%; microglia + 5-BDBD, 212 AE 18%; LPS-microglia, 277 AE 31%; LPS-microglia + 5-BDBD, 242 AE 25%; n = 9 for all conditions). (D) Bar representation of FF. Genetic deletion of P2X 4 R (P2X 4 R KO) abolished the LPSmicroglia induced decrease in FF (control, 482 AE 39%; P2X 4 R KO, 419 AE 43%; microglia, 430 AE 18%; microglia + P2X 4 R KO, 377 AE 31%; LPS-microglia, 281 AE 18%; LPS-microglia + P2X 4 R KO, 337 AE 23%; n = 9 for all conditions). (E) Graphical representation of the PPR. The LPS-microglia-induced decrease in the PPR was preserved in P2X 4 R KO slices (control, 392 AE 32%; P2X 4 R KO, 253 AE 32%; microglia, 357 AE 35%; microglia + P2X 4 R KO, 216 AE 57%; LPS-microglia, 277 AE 31%; LPS-microglia + P2X 4 R KO, 265 AE 41%; n = 9 for all conditions). (F) Graphical representation of FF. Addition of ARL67156 (10 lM) mimicked the LPS-microglia-induced decrease in FF, whereas prior blockade of P2X 4 Rs by 5-BDBD (10 lM) prevented this effect (control, 482 AE 39%, n = 9; ARL67156, 183 AE 29%, n = 3; LPS-microglia, 281 AE 18%, n = 9; ARL67156 + 5-BDBD, 442 AE 97%, n = 3). (G) Graphical representation of the PPR. Increasing the level of endogenous ATP with ARL67156 (10 lM) had no effect on the PPR (control, 392 AE 32%, n = 9; ARL67156, 324 AE 71%, n = 3; LPS-microglia, 277 AE 31%, n = 9; ARL67156 + 5-BDBD, 281 AE 78%, n = 3). Values in all graphs are mean AE SEM. *P < 0.05, **P < 0.01 and ***P < 0.001 from one-way ANOVA followed by a Newmann-Keuls multiple comparison test.
LPS-microglia, 281 AE 18%; P < 0.001, n = 9; ARL67156, 183 AE 29%; P < 0.001, n = 3) (Fig. 5F ), whereas prior blockade of P2X 4 Rs by 5-BDBD (10 lM) prevented this effect (ARL67156 + 5-BDBD, 442 AE 97%; P < 0.02, n = 3) (Fig. 5F ). In contrast, prior blockade of P2X 4 Rs by 5-BDBD, before addition of ARL67156, had no further effect on PPF (Fig. 5G ).
ATP and adenosine modulate synaptic plasticity independently of each other
Our data strongly suggest that extracellular ATP released from LPSmicroglia acts on P2X 4 Rs to modulate FF, and that adenosine catabolized from extracellular ATP acts on A 1 Rs to modulate PPF. Adenosine being the end-product of ATP, we had to disentangle any possible indirect effects of ATP on PPF or adenosine on FF. For this purpose, FF and PPF were investigated in the presence of DPCPX in slices obtained from P2X 4 R KO mice. The LPS-microglia-induced decrease in FF (Fig. 6A and B) was reduced in P2X 4 R KO mice (LPS-microglia, 281 AE 18%; LPS-microglia + P2X 4 R KO, 337 AE 23%; P < 0.05, n = 9), but was preserved in the presence of DPCPX (LPS-microglia + P2X 4 R KO + DPCPX, 402 AE 38%; P < 0.001, n = 5) (Fig. 6B) . This indicates that A 1 Rs have no effect on the modulation of FF by P2X 4 Rs. Conversely, genetic deletion of P2X 4 Rs did not prevent the ability of DPCPX to block the LPS-microglia-induced decrease in PPF ( Fig. 6C and D) . Hence, ATP released by LPS-microglia and its end-product adenosine act independently on P2X 4 Rs and A 1 Rs, respectively, to modulate short-term synaptic plasticity.
Discussion
Over the last 10 years, the notion of microglia as passive sentinels within the brain has been noticeably widened, and microglia are now acknowledged to constitute a new partner in synaptic function (Tremblay et al., 2010) [reviewed in Kettenmann et al. (2013) ]. Indeed, microglia can secrete a full array of neuroactive molecules, including several proinflammatory cytokines (interleukin-1b, interleukin-6, and tumour necrosis factor-a), trophic factors such as brain-derived neurotrophic factor, and also neurotransmitters such as ATP, glycine, and glutamate [reviewed in Kettenmann et al. (2011) ]. In the present study, we focused on the putative effect of microglia-derived purines on synaptic function at MF-CA3 synapses.
In this experimental paradigm, N9 microglia were previously challenged with an immune stimulus (LPS) to induce them to release ATP (George et al., 2015) , and were then added to hippocampal slices. Combining pharmacological, electrophysiological and immunohistochemical approaches, our study demonstrated that ATP released Blockade of A 1 R by DPCPX (100 nM) had no effect on the inhibitory effect of P2X 4 R KO on the LPS-microglia-induced change in FF (control, 482 AE 39%, n = 9; P2X 4 R KO + DPCPX, 434 AE 98%, n = 5; LPS-microglia, 281 AE 18%, n = 9; LPS-microglia + P2X 4 R KO, 337 AE 23%, n = 9; LPSmicroglia + P2X 4 R KO + DPCPX, 402 AE 38%, n = 5). Rs had no effect on the DPCPX-induced inhibition of the LPS-microglia-induced decrease in the PPR (control, 392 AE 32%, n = 9; P2X 4 R KO + DPCPX, 388 AE 66%, n = 5; LPS-microglia, 277 AE 31%, n = 9; LPS-microglia + DPCPX, 383 AE 35%, n = 9; LPS-microglia + P2X 4 R KO + DPCPX, 417 AE 36%, n = 5). Values in all graphs are mean AE SEM. *P < 0.05, **P < 0.01 and ***P < 0.001 from one-way ANOVA followed by a Neumann-Keuls multiple comparison test.
by LPS-microglia modulates MF-CA3 synaptic transmission both directly via presynaptic P2X 4 Rs and through its metabolite adenosine, by acting on presynaptic A 1 Rs. Each pathway selectively modulates a different type of short-term presynaptic plasticity at MF-CA3 synapses, namely FF for P2X 4 Rs and PPF for A 1 Rs. This study reveals complex crosstalk between microglial release of ATP, purinergic receptor activation, and hippocampal synaptic function.
P2X 4 Rs modulate basal synaptic transmission
Basal synaptic transmission at MF-CA3 synapses is governed by presynaptic intracellular calcium homeostasis and cAMP levels (Nicoll & Schmitz, 2005) . Within the ionotropic P2X receptor family, P2X 4 Rs show the highest permeability for calcium (Soto et al., 1996; Burnstock et al., 2011) , and, through this property, P2X 4 Rs can modulate basal synaptic transmission. In good agreement with this, the blockade of P2X 4 Rs by 5-BDBD or their genetic deletion in P2X 4 R KO mice decreased basal synaptic transmission, whereas ivermectin, which selectively potentiates ATP-induced currents at P2X 4 Rs (Khakh et al., 1999; Priel & Silberberg, 2004) , increased it. As expected, the degradation of extracellular ATP by apyrase also decreased basal synaptic transmission. All together, these results suggest that extracellular ATP tonically modulates basal synaptic transmission, most likely by increasing the presynaptic calcium concentration via its influx through P2X 4 Rs.
Interestingly, the end-product of ATP catabolism, i.e. adenosine, by acting on presynaptic A 1 Rs, also tonically decreases basal synaptic transmission (Moore et al., 2003; Kukley et al., 2005; Rebola et al., 2008) , probably through the direct A 1 R inhibition of calcium influx via presynaptic P/Q-type and N-type calcium channels (Gundlfinger et al., 2007) . Our results suggest that purines modulate basal synaptic transmission via a complex interplay between ATP and adenosine signalling, which produce opposite effects.
Microglia-derived ATP impacts on FF
Owing to their unusual low initial glutamate release probability, MF-CA3 synapses show a large facilitation of response amplitudes of up to 500-600% when the frequency of stimulation is increased from 0.1 Hz to 1 Hz. This unique form of short-term plasticity, termed FF, was decreased by 40-50% following the addition of LPSmicroglia. Several lines of evidence clearly demonstrate that ATP produced by LPS-microglia and acting on P2X 4 Rs was responsible for this effect: first, the addition of unstimulated microglia to acute slices had no effect on FF; second, the decrease in FF following the addition of LPS-microglia was prevented by apyrase but potentiated by ARL67156; third, it was blocked by PPADS, a broad-spectrum P2X receptor antagonist, but also by 5-BDBD; fourth, it was mimicked by ivermectin; fifth, it was absent in P2X 4 R KO mice; and sixth, it was insensitive to the A 1 R ligands DPCPX (antagonist) and CCPA (agonist), in agreement with previous work (Rebola et al., 2008) .
It is not known for certain how FF is governed at MF-CA3 synapses, and different mechanisms have been proposed, such as the involvement of calcium/calmodulin-dependent protein kinase II (Salin et al., 1996) , presynaptic kainate receptors (Contractor et al., 2001) , or presynaptic voltage-dependent calcium channels (Gundlfinger et al., 2007) . Our results show that P2X 4 Rs only control FF in the presence of sufficient amounts of extracellular ATP, which are probably provided by activated microglia, whereas, in the absence of LPS-microglia, FF is insensitive to P2X 4 R blockade.
Microglia-derived adenosine but not ATP impacts on PPF
The decrease in PPF induced by LPS-microglia, which was preserved in the presence of PPADS or 5-BDBD but also in P2X 4 R KO slices, strongly suggests that adenosine but not ATP was involved in this effect. Activation of A 1 Rs at MF-CA3 synapses is known to inhibit synaptic transmission (Scanziani et al., 1992; Moore et al., 2003; Kukley et al., 2005) , and its presynaptic localization has been confirmed by electron microscopy (Rebola et al., 2008) . The blockade by DPCPX of the decrease in PPF induced by LPS-microglia and its mimicking by CCPA are good evidence that adenosine resulting from the degradation of microglia-derived ATP modulates PPF. Unexpectedly, the blockade of P2X 4 Rs by 5-BDBD on its own also reduced PPF. This could indicate that endogenous ATP in the presence of receptors blocked by 5-BDBD would be more readily available to be converted into adenosine, activating A 1 R and leading to a decrease in PPF. Hence, PPF was not affected in P2X 4 R KO mice, supporting our contention that the effect of 5-BDBD involves greater availability of adenosine acting on A 1 Rs rather than an effect of P2X 4 R.
Owing to a very low initial release probability, the PPF at MF-CA3 synapses is assumed to be directly linked to the probability of glutamate release, which is dependent on the residual calcium concentration in the presynaptic terminal (Salin et al., 1996; Nicoll & Schmitz, 2005) . Therefore, one could expect that microglia-derived adenosine acting on A 1 Rs by reducing calcium influx into MF terminals (Gundlfinger et al., 2007) would decrease PPF instead of increasing it. However, conflicting results have been reported for the impact of A 1 R activation on PPF at MF-CA3 synapses, ranging from a reduction by half of PPF by DPCPX (Moore et al., 2003) to no effect at all (Kukley et al., 2005) . These opposite results were attributed to differences in the ambient levels of adenosine in slices. Our results are consistent with a moderate level of ambient adenosine, as shown by the weak increase in basal synaptic transmission caused by DPCPX, similarly to what was previously reported (Kukley et al., 2005; Rebola et al., 2008) , and by the lack of a significant effect on PPF.
Pathophysiological relevance of microglia-derived purine modulation of MF-CA3 synaptic plasticity There is compelling evidence that the purinergic system is instrumental in neuroinflammation (Di Virgilio et al., 2009) , which can impact on synaptic function (Ben Achour & Pascual, 2010; Pascual et al., 2012) . ATP is a major trigger of microglia activation through P2X 4 Rs and P2X 7 receptors (Di Virgilio et al., 2009; Koizumi et al., 2013) , and adenosine also regulates microglia responses through the activation of A 2A Rs in vivo (Rebola et al., 2011) , by controlling the microglial production of inflammatory cytokines, and growth factors such as BDNF and ATP (Gomes et al., 2013; George et al., 2015) . By taking advantage of a simple paradigm based on the addition of activated N9 microglia releasing ATP, the present study provides evidence that microglia-derived purines in a neuroinflammatory paradigm modulate, via presynaptic P2X 4 Rs and A 1 Rs, different forms of presynaptic short-term plasticity at MF-CA3 synapses. However, the simplicity of the paradigm used also introduced some limitations in the mechanistic process underlying this control of short-term plasticity by microglia-derived ATP. Indeed, our experimental approach does not allow us to rule out the participation of endogenous microglia, astrocytes and/or neurons in possible amplification of the N9 microglia-derived ATP to control presynaptic short-term plasticity at MF-CA3 synapses. In this respect, a recent study showed that the production of tumour necrosis factor-a and ATP by microglia was driving nearby astrocytes to release ATP, promoting, in turn, astroglial release of glutamate and a subsequent increase in CA1 synaptic transmission in acute hippocampal slices (Pascual et al., 2012) . However, this documented ATP-induced ATP release from astrocytes occurs only for ATP concentrations in the high micromolar range (Anderson et al., 2004) , whereas we have previously estimated that N9 microglia release nanomolar concentrations of ATP (George et al., 2015) . Certainly, future studies will be required to unravel the intricate interplay between different cell types in the purinergic control of presynaptic short-term plasticity at MF-CA3 synapses triggered by a neuroinflammation-associated increase in the concentration of microgliaderived ATP.
The CA3 subregion of the hippocampus has been reported to be involved in the encoding, storage and subsequent retrieval of memories (Nakazawa et al., 2003; Bischofberger et al., 2006; Kesner, 2007) . Owing to the sparse connectivity between dentate gyrus granule cells and CA3 pyramidal neurons and the prominent ability of MF-CA3 synapses to facilitate markedly the MF pathway has been particularly involved in the pattern separation process (Bischofberger et al., 2006; Gilbert & Kesner, 2006; Leutgeb et al., 2007; Neves et al., 2008) . Therefore, a decrease in short-term plasticity induced by neuroinflammation could impact on the pattern separation process. Relevant to this, it is well known that murine models of Alzheimer's disease, which show prominent neuroinflammation, have impaired spatial memory, as is also found in Alzheimer's patients. It would be interesting to use behavioural paradigms to test the pattern separation process in mice with conditional deletion of P2X 4 Rs and/ or A 1 Rs in granule cells, in order to test the possible involvement of this subnetwork.
